Peter J Ell
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Christ E, Reubi J, Perren A, Gloor B, Seufert J, Ell P, Stettler C, Fischli S, Clerici T, Brändle M, Caplin M, Nicolas G, Béhé M, Ederer S, Wild D, Forrer F. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013; 1:115-22.
25.07.2013Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
25.07.2013Lancet Diabetes Endocrinol 2013; 1:115-22
Christ Emanuel, Reubi Jean Claude, Perren Aurel, Gloor Beat, Seufert Jochen, Ell Peter J, Stettler Christoph, Fischli Stefan, Clerici Thomas, Brändle Michael, Caplin Martyn E, Nicolas Guillaume, Béhé Martin, Ederer Susanne, Wild Damian, Forrer Flavio
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Wild D, Ell P, Perren A, Bomanji J, Weber W, Seufert J, Brändle M, Forrer F, Kurzawinski T, Caplin M, Christ E, Reubi J. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-8.
16.06.2011Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
16.06.2011J Nucl Med 2011; 52:1073-8
Wild Damian, Ell Peter J, Perren Aurel, Bomanji Jamshed, Weber Wolfgang A, Seufert Jochen, Brändle Michael, Forrer Flavio, Kurzawinski Tom R, Caplin Martyn E, Christ Emanuel, Reubi Jean Claude